https://www.selleckchem.com/products/gossypol.html
3% 1.7%; OR 0.18; 95% CI 0.06-0.59). Multivariable analysis confirmed that patients with incidental PE were at lower risk to die (adjusted OR 0.43; 95%CI 0.34-0.56). Overall, 29 patients (0.9%) developed symptomatic PE recurrences, and 122 (3.8%) had major bleeding. There were no significant differences in PE recurrences (OR 0.62; 95%CI 0.25-1.54) or major bleeding (OR 0.78; 95%CI 0.51-1.18). Cancer patients with incidental PE had a lower mortality rate than those with clinically-suspected and confirmed PE. Further studies are required
Like
Comment
Share
